Patents Assigned to LifeRaft Biosciences, Inc.
  • Patent number: 11155679
    Abstract: Provided herein are long circulating material free (LCMF) poloxamer compositions and uses thereof. In particular, provided are LCMF poloxamer 188 compositions and uses thereof. Also provided are supercritical fluid extraction (SFE) methods and high pressure (subcritical) methods for preparing poloxamer compositions, particularly the LCMF poloxamer compositions.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: October 26, 2021
    Assignee: LifeRaft Biosciences, Inc.
    Inventors: R. Martin Emanuele, Mannarsamy Balasubramanian, Stewart V. Smith
  • Publication number: 20200055983
    Abstract: Provided herein are long circulating material free (LCMF) poloxamer compositions and uses thereof. In particular, provided are LCMF poloxamer 188 compositions and uses thereof. Also provided are supercritical fluid extraction (SFE) methods and high pressure (subcritical) methods for preparing poloxamer compositions, particularly the LCMF poloxamer compositions.
    Type: Application
    Filed: October 23, 2019
    Publication date: February 20, 2020
    Applicant: LifeRaft Biosciences, Inc.
    Inventors: R. Martin Emanuele, Mannarsamy BALASUBRAMANIAN, Stewart V. SMITH
  • Patent number: 10501577
    Abstract: Provided herein are long circulating material free (LCMF) poloxamer compositions and uses thereof. In particular, provided are LCMF poloxamer 188 compositions and uses thereof. Also provided are supercritical fluid extraction (SFE) methods and high pressure (subcritical) methods for preparing poloxamer compositions, particularly the LCMF poloxamer compositions.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: December 10, 2019
    Assignee: LifeRaft Biosciences, Inc.
    Inventors: R. Martin Emanuele, Mannarsamy Balasubramanian, Stewart V. Smith